Novo Nordisk and NanoVation sign $600m deal in rare and cardiometabolic diseases
NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product sales.
AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis after FDA nod
Organon makes $1.2bn play for Roivant’s immuno-dermatology subsidiary
Lupin and Takeda to commercialise Vonoprazan in India
FDA approves Accord BioPharma’s HERCESSI for cancer treatment
Gavi to obtain 500,000 mpox vaccine doses from Bavarian Nordic
FDA approves MSD’s KEYTRUDA as first-line MPM treatment
“Leave politics out of healthcare” – controversy swirls around BIOSECURE Act
Analysis
View More
Themes
View MoreGilead and Genesis partner to create novel therapies using AI
Genesis is entitled to receive $35m in upfront payment for three targets.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
Leading clinical trials companies in the artificial intelligence theme
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
CMN-005 by CoImmune for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
As mpox spreads, ‘national governments have a moral responsibility to help’
Combating Pharmaceutical Crime with On-Dose Authentication
Syntekabio and Enamine partner for AI-based drug development
Novavax wins FDA emergency approval for updated Covid-19 vaccine